Trial Profile
Evaluation of Immunohistological Pattern in Patients With Uncomplicated Symptomatic Diverticular Disease and Correlation Between Intraluminal Bacterial Flora and Phlogosis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Mar 2014
Price :
$35
*
At a glance
- Drugs Rifaximin (Primary)
- Indications Diverticulitis
- Focus Pharmacodynamics
- 17 Mar 2014 New trial record